These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4879677)

  • 1. Use of haloperidol in a "hard-core" chronic schizophrenic population.
    Lee H
    Psychosomatics; 1968; 9(5):267-71. PubMed ID: 4879677
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative trial of haloperidol and thioridazine: management of chronic schizophrenia.
    Weston MJ; Bentley R; Unwin A; Morris M; Harper MA
    Aust N Z J Psychiatry; 1973 Mar; 7(1):52-7. PubMed ID: 4579393
    [No Abstract]   [Full Text] [Related]  

  • 3. Haloperidol--new addition to the drug treatment of schizophrenia.
    Stewart A; Lafave HG; Segovia G
    Behav Neuropsychiatry; 1969 Oct; 1(7):23-8. PubMed ID: 4907607
    [No Abstract]   [Full Text] [Related]  

  • 4. CI-601, a butyrophenone derivative, in the treatment of chronically withdrawn schizophrenic patients.
    Villeneuve C; Ananth JV; Ban TA; Lehmann HE
    Curr Ther Res Clin Exp; 1970 Apr; 12(4):223-9. PubMed ID: 4985943
    [No Abstract]   [Full Text] [Related]  

  • 5. Flupenthixol in chronic schizophrenic inpatients: a controlled comparison with haloperidol.
    Ehmann TS; Delva NJ; Beninger RJ
    J Clin Psychopharmacol; 1987 Jun; 7(3):173-5. PubMed ID: 3298328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A controlled comparison of haloperidol and fluphenazine in chronic treatment-resistant schizophrenics.
    Hall WB; Vestre ND; Schiele BC; Zimmermann R
    Dis Nerv Syst; 1968 Jun; 29(6):405-8. PubMed ID: 4877748
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of haloperidol and penfluridol on the learning capacity of the schizophrenic.
    Van Lommel R; Baro F; Dom R
    Arzneimittelforschung; 1974 Jul; 24(7):1072-4. PubMed ID: 4605278
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparison of haloperidol and thioridazine HC1 in chronic treatment-resistant schizophrenics.
    Gonier T; Schiele BC; Vestre ND
    Behav Neuropsychiatry; 1970; 2(3):47-9 passim. PubMed ID: 4913152
    [No Abstract]   [Full Text] [Related]  

  • 9. Further studies of the butyrophenone, CI-601, in chronic schizophrenic patients.
    Edwards JG; Simpson GM
    Curr Ther Res Clin Exp; 1968 Oct; 10(10):520-8. PubMed ID: 4971467
    [No Abstract]   [Full Text] [Related]  

  • 10. Treatment of acute exacerbations in chronic schizophrenic patients.
    Towler ML; Wick PH
    Int J Neuropsychiatry; 1967 Aug; 3():Suppl l:61-7. PubMed ID: 4860982
    [No Abstract]   [Full Text] [Related]  

  • 11. A double-blind comparison of haloperidol oral concentrate, haloperidol solutabs and placebo in the treatment of chronic schizophrenia.
    Ota KY; Kurland AA
    J Clin Pharmacol New Drugs; 1973; 13(2):99-110. PubMed ID: 4568299
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of haloperidol and Trifluoperazine. (A double-blind, controlled study on chronic schizophrenic outpatients).
    Luckey WT; Schiele BC
    Dis Nerv Syst; 1967 Mar; 28(3):181-6. PubMed ID: 4381424
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical efficacy of haloperidol in chronic psychotic patients.
    Lapolla A
    Int J Neuropsychiatry; 1967 Aug; 3():Suppl l:68-77. PubMed ID: 6051725
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of chronic schizophrenic patients with haloperidol and chlorpromazine combined.
    Jones B; Lehmann HE; Saxena BM; Ban TA
    Curr Ther Res Clin Exp; 1968 Jun; 10(6):276-8. PubMed ID: 4969832
    [No Abstract]   [Full Text] [Related]  

  • 15. A controlled comparative study of chlorprothixene vs. haloperidol in chronic schizophrenia.
    Fux M; Belmaker RH
    Isr J Psychiatry Relat Sci; 1991; 28(1):37-40. PubMed ID: 1830565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher than usual dosage of haloperidol: a pilot study in chronic schizophrenics.
    Pacquay M; Brasseur F
    Proc R Soc Med; 1976; 69 suppl 1(Suppl 1):46-9. PubMed ID: 798190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Long-term therapy of chronic schizophrenic patients with haloperidol decanoate].
    Roncoroni D
    Psychiatr Prax; 1984 Mar; 11(2):56-8. PubMed ID: 6144121
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loxapine succinate: a double-blind comparison with haloperidol and placebo in acute schizophrenics.
    Selman FB; McClure RF; Helwig H
    Curr Ther Res Clin Exp; 1976 Jun; 19(6):645-52. PubMed ID: 819222
    [No Abstract]   [Full Text] [Related]  

  • 19. Somatosensory-evoked potential changes during haloperidol treatment of chronic schizophrenics.
    Saletu B; Saletu M; Itil T; Marasa J
    Biol Psychiatry; 1971; 3(4):299-307. PubMed ID: 5163816
    [No Abstract]   [Full Text] [Related]  

  • 20. Open study with bromperidol in hospitalized chronic schizophrenic patients.
    Hermans W
    Acta Psychiatr Belg; 1978; 78(1):89-95. PubMed ID: 347883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.